| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698934 | Clinical Oncology | 2011 | 7 Pages |
Abstract
Concomitant adjuvant chemoradiotherapy with weekly cisplatin seems to be a feasible and well-tolerated therapeutic approach in 'unfit' patients. Clinical results seem to be at least comparable with those previously reported. However, to draw any definitive conclusion, large confirmatory phase III randomised trials are demanded.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M. Rampino, U. Ricardi, F. Munoz, A. Reali, C. Barone, A.R. Musu, V. Balcet, P. Franco, R. Grillo, S. Bustreo, G. Pecorari, A. Cavalot, P. Garzino Demo, L. Ciuffreda, R. Ragona, M. Schena,